Alemtuzumab for Refractory Celiac Disease in a Patient at Risk for Enteropathy-Associated...
S. Vivas,
J. M. R. de Morales,
F. Ramos,
and
D. Suárez-Vilela
- 8 Jun, 2006
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
